NCT06553625

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 200 (estimated)
• Sponsor: Boston Scientific Corporation · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.

Detailed description

The objective of this study is to compile real-world outcomes of Boston Scientific Corporation commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.

Conditions

• Parkinson Disease
• Dystonia
• Essential Tremor
• Movement Disorders

Interventions

Type	Name	Description
DEVICE	Radiofrequency Ablation	Radiofrequency Ablation used in the central nervous system (CNS) in functional neurosurgery

Timeline

• Start date: 2024-01-29
• Primary completion: 2035-12-01
• Completion: 2035-12-01
• First posted: 2024-08-14
• Last updated: 2026-04-06

Locations

4 sites across 2 countries: Germany, United Kingdom

Regulatory

• FDA-regulated device study